Beyond the Great Wall: Entering and Succeeding in China’s MedTech Market

China’s vast and rapidly evolving MedTech market presents both opportunities and regulatory hurdles for global medical device companies. Navigating this complex environment requires a detailed understanding of its unique legal framework, from initial product registration to post-market compliance.

For Part IX of our Critical Medical Device Issues series, join our U.S.- and China-based lawyers to gain a comprehensive understanding of the Chinese MedTech landscape. Our speakers will guide you through the complexities of the regulatory landscape, explaining how to navigate clinical trial requirements, register products through standard or expedited pathways, and manage ongoing post-market compliance. We will also analyze the potential impact of the draft Medical Device Administration Law, the first comprehensive law regulating China’s MedTech sector; the evolving volume-based procurement system; and the impact of the Personal Information Protection Law and other regulations on cross-border data transfer on the MedTech industry.

This session is essential for executives, in-house counsel, and regulatory and compliance professionals involved in or considering entering the Chinese market. Attendees will gain actionable insights and strategic guidance to mitigate risks and capitalize on opportunities in one of the world’s most important healthcare markets.

Webinar Series Alert